Saturday, 23 January 2021
05:26 | 25/4/18
StockNewsJournal
Argos Therapeutics, Inc. (ARGS) currently trades with a market capitalization of $4.71 Million. That value represents a market adjusting for revenues that have been growing by 921.11 % on a quarterly year/year basis as of the company's last quarterly ...
more»21:56 | 24/4/18
Post Analyst
Ensco plc (NYSE:ESV) recorded a trading volume of 8.19 million shares, below its 90-day volume average of 13.19 million shares. The stock kicked off the session at $5.9 and later approached $6.01 with a change of 0.5%.
more»09:30 | 24/4/18
Equities.com
Shares of Argos Therapeutics Inc. (ARGS) sank into a new 52-week low yesterday, and could be a company to watch at the open.
more»09:30 | 24/4/18
Equities.com
Argos Therapeutics Inc. (ARGS) traded on unusually high volume on Apr. 23, as the stock lost 2.13% to close at $0.28. On the day, Argos Therapeutics Inc. saw 1.47 million shares trade hands on 1,932 trades. Considering that the stock averages only a ...
more»Minerva Advsr Limited Liability stated it has 0.04% of its portfolio in Aehr Test Systems (NASDAQ:AEHR). Waddell And Reed Finance Incorporated accumulated 272,500 shares.
more»01:52 | 18/4/18
The Casual Smart
Awm Investment Incorporated has 0.95% invested in Aehr Test Systems (NASDAQ:AEHR). G2 Partners Limited Co holds 361,056 shs.
more»00:22 | 18/4/18
Frisco Fastball
25,760 are owned by Hgk Asset Inc. California-based Aperio Grp Lc has invested 0% in Aceto Corporation (NASDAQ:ACET). Renaissance Technologies Lc reported 232,700 shares or 0% of all its holdings.
more»No Risk Alert Here: Before we dive into any analysis we simply note that Acorda Therapeutics Inc (NASDAQ:ACOR) risk is neither elevated nor depressed.
more»03:11 | 17/4/18
Macon Daily
Itron has a consensus target price of $84.40, indicating a potential upside of 19.55%. Given Itron's higher possible upside, analysts clearly believe Itron is more favorable than Aehr Test Systems. Volatility and Risk. Aehr Test Systems has a beta of 0 ...
more»23:20 | 16/4/18
Nasdaq Journal
Shares of Aehr Test Systems (NASDAQ:AEHR) closed the previous trading session at $2.59, experiencing a change of 11.88% with 254,355 shares trading hands.
more»23:03 | 16/4/18
The Lincolnian Online
Alliancebernstein L.P. boosted its position in shares of Acorda Therapeutics (NASDAQ:ACOR) by 40.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
more»22:30 | 16/4/18
Macon Daily
Aehr Test Systems has higher earnings, but lower revenue than Analogic. Aehr Test Systems is trading at a lower price-to-earnings ratio than Analogic, indicating that it is currently the more affordable of the two stocks.
more»22:30 | 16/4/18
Macon Daily
Pluristem Therapeutics currently has a consensus target price of $4.00, suggesting a potential upside of 230.58%. Acorda Therapeutics has a consensus target price of $21.83, suggesting a potential downside of 6.50%. Given Pluristem Therapeutics ...
more»23:48 | 15/4/18
StocksGeeks
Aehr Test Systems (AEHR):. Checking on recent price levels compared to prior highs and lows, we have seen that Aehr Test Systems (AEHR) recently traded -7.50% away from the 50-day high and moved 22.17% from the 50-day low. Taking a wider observation ...
more»23:37 | 13/4/18
Newberry Journal
The Shareholder Yield (Mebane Faber) of Sociedad Minera Cerro Verde S.A.A. BVL:CVERDEC1 is 0.07188. This number is calculated by looking at the sum of the dividend yield plus percentage of sales repurchased and net debt repaid yield.
more»
| Code | Last | Change |
|---|
| COMP | 13,531 | 74 |  | 0.55% |
| DJI | 31,176 | 12 |  | 0.04% |
| SP500 | 3,853 | 1 | | 0.03% |
| DAX | 13,466 | 236 | | 1.78% |
| FTSE | 7,488 | 5 | | 0.07% |
| NI225 | 22,420 | 408 | | 1.86% |
| TWI | 72.91 | 0.21 | | 0.29% |